NAGE vs SCHW · P/E 59, rev $61.3M vs P/E 19, rev $13.55B
Niagen Bioscience, Inc. (NAGE) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Richard Andrew Wurster C.F.A., CMT.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the NAGE and SCHW stock pages for the full models.
Not investment advice.